相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer metastasis: Mechanisms of inhibition by melatonin
Shih-Chi Su et al.
JOURNAL OF PINEAL RESEARCH (2017)
Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma
Luiz Gustavo A. Chuffa et al.
ENDOCRINE-RELATED CANCER (2016)
Melatonin Regulates Angiogenic Factors Under Hypoxia in Breast Cancer Cell Lines
Bruna Victorasso Jardim-Perassi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Melatonin as an antioxidant: under promises but over delivers
Russel J. Reiter et al.
JOURNAL OF PINEAL RESEARCH (2016)
Quantitative Proteomic Profiling Reveals That Diverse Metabolic Pathways Are Influenced by Melatonin in an in Vivo Model of Ovarian Carcinoma
Luiz Gustavo A. Chuffa et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis
Lixia He et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2016)
Antiangiogenic therapies in ovarian cancer
Alexander Reinthaller
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2016)
Melatonin attenuates the TLR4-mediated inflammatory response through MyD88-and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer
Luiz Gustavo A. Chuffa et al.
BMC CANCER (2015)
Melatonin: an inhibitor of breast cancer
Steven M. Hill et al.
ENDOCRINE-RELATED CANCER (2015)
Melatonin: an ancient molecule that makes oxygen metabolically tolerable
Lucien C. Manchester et al.
JOURNAL OF PINEAL RESEARCH (2015)
Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model
Peter Orendas et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2014)
Expression of the MT1 Melatonin Receptor in Ovarian Cancer Cells
Karolina Jablonska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Effect of Melatonin on Tumor Growth and Angiogenesis in Xenograft Model of Breast Cancer
Bruna Victorasso Jardim-Perassi et al.
PLOS ONE (2014)
Melatonin Attenuates Her-2, p38 MAPK, p-AKT, and mTOR Levels in Ovarian Carcinoma of Ethanol-Preferring Rats
Grazielle M. Ferreira et al.
JOURNAL OF CANCER (2014)
Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells
S. Carbajo-Pescador et al.
BRITISH JOURNAL OF CANCER (2013)
The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis
Lei Yu et al.
GYNECOLOGIC ONCOLOGY (2013)
Melatonin Anticancer Effects: Review
Giuseppe Di Bella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
Sampurna Chatterjee et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells
Virginia Alvarez-Garcia et al.
JOURNAL OF PINEAL RESEARCH (2013)
Identification of Potential Biomarkers for Ovarian Cancer by Urinary Metabolomic Profiling
Tao Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth
Marc A. Becker et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Characterization of Chemically Induced Ovarian Carcinomas in an Ethanol-Preferring Rat Model: Influence of Long-Term Melatonin Treatment
Luiz Gustavo A. Chuffa et al.
PLOS ONE (2013)
Melatonin and ethanol intake exert opposite effects on circulating estradiol and progesterone and differentially regulate sex steroid receptors in the ovaries, oviducts, and uteri of adult rats
Luiz Gustavo A. Chuffa et al.
REPRODUCTIVE TOXICOLOGY (2013)
Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells
Ji-Hyun Kim et al.
JOURNAL OF PINEAL RESEARCH (2012)
Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma
Sheng-Tan Wang et al.
ONCOLOGY REPORTS (2012)
Long-Term Exogenous Melatonin Treatment Modulates Overall Feed Efficiency and Protects Ovarian Tissue Against Injuries Caused by Ethanol-Induced Oxidative Stress in Adult UChB Rats
Luiz Gustavo A. Chuffa et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2011)
Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancer
R. A. Burger
ANNALS OF ONCOLOGY (2011)
Long-term melatonin treatment reduces ovarian mass and enhances tissue antioxidant defenses during ovulation in the rat
L. G. A. Chuffa et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2011)
Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells
Sara Proietti et al.
JOURNAL OF PINEAL RESEARCH (2011)
A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases
Joerg H. Stehle et al.
JOURNAL OF PINEAL RESEARCH (2011)
Melatonin reduces LH, 17 beta-estradiol and induces differential regulation of sex steroid receptors in reproductive tissues during rat ovulation
Luiz Gustavo A. Chuffa et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding
Stephane Germain et al.
CURRENT OPINION IN HEMATOLOGY (2010)
Effects of Chronic Red Wine Consumption on the Expression of Vascular Endothelial Growth Factor, Angiopoietin 1, Angiopoietin 2, and Its Receptors in Rat Erectile Tissue
Delminda R. G. L. M. Neves et al.
JOURNAL OF FOOD SCIENCE (2010)
Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia
Shi-Young Park et al.
JOURNAL OF PINEAL RESEARCH (2010)
Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
Stephen G. Grant et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure
P. B. Hoyer et al.
GYNECOLOGIC ONCOLOGY (2009)
Functional significance of VEGFR-2 on ovarian cancer cells
Whitney A. Spannuth et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Melatonin down-regulates HIF-1α expression through inhibition of protein translation in prostate cancer cells
Jong-Wook Park et al.
JOURNAL OF PINEAL RESEARCH (2009)
Vascular endothelial growth factor expression in ovarian cancer: A model for targeted use of novel therapies?
Timothy J. Duncan et al.
CLINICAL CANCER RESEARCH (2008)
Melatonin modulates the expression of VEGF and HIF-1α induced by CoCl2 in cultured cancer cells
Min Dai et al.
JOURNAL OF PINEAL RESEARCH (2008)
Transforming growth factor-β1, transforming growth factor-β2, and transforming growth factor-β3 enhance ovarian cancer metastatic potential by inducing a smad3-dependent epithelial-to-mesenchymal transition
Thuy-Vy Do et al.
MOLECULAR CANCER RESEARCH (2008)
Alcohol intake and breast cancer risk among young women
Paula Berstad et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Molecular mechanisms of alcohol-mediated carcinogenesis
Helmut K. Seitz et al.
NATURE REVIEWS CANCER (2007)
Common antiepileptic drugs in pregnancy in women with epilepsy
J. Henderson et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Regulators of angiogenesis and strategies for their therapeutic manipulation
M Milkiewicz et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
DJ Manalo et al.
BLOOD (2005)
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma
N Nishida et al.
CANCER (2004)
Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo
ES Wang et al.
BLOOD (2004)
Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
HF Dvorak
JOURNAL OF CLINICAL ONCOLOGY (2002)
Activation of the HIF pathway in cancer
PH Maxwell et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2001)
分享论文
